National indication protocol for proton radiotherapy in esophageal cancer patients in the Netherlands
A national indication protocol enabling model-based selection for PRT in EC was successfully implemented in the Netherlands. The NIPP describes eligibility criteria for proton therapy reimbursement and enables reimbursement for individual patients who are expected to benefit from PRT.
Authors
- Rob H.A. Verhoeven (ORCID: https://orcid.org/0000-0001-9678-1611)
- Christina T. Muijs
- Frank J. W. M. Dankers (ORCID: https://orcid.org/0009-0000-1354-3723)
- Ewoud Schuit (ORCID: https://orcid.org/0000-0002-9548-3214)
- G. Ebrahimi (ORCID: https://orcid.org/0000-0001-7767-911X)
- Irene M. Lips (ORCID: https://orcid.org/0000-0001-9636-3137)
- Maaike Berbée
- Joost J. Nuyttens (ORCID: https://orcid.org/0009-0002-5021-1597)
- Yvonne L.B. Klaver
- Karin Müller
Institutions
- University Medical Center Groningen (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Erasmus MC (NL)
- University Medical Center Utrecht (NL)
- Instituut Verbeeten (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
- Radiotherapiegroep (NL)
- Deventer Ziekenhuis (NL)
- Maastro Clinic (NL)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1016/j.radonc.2025.111164
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00